News-Medical.Net on MSN14d
Solascure enrols first patient in a next phase II clinical trial to advance Aurase Wound GelSOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback